Amlodipine is a medicine brand authorised in South Africa. This page provides limited product identification information only .
Medicine name : Amlodipine
Country: South Africa
Schedule: S3
Active ingredients :
| Product / Strength | Active Ingredient | Amount / Details | Inactive Ingredient |
|---|---|---|---|
| AMLODIPINE 5 GDC | Amlodipine besylate | Equivalent to amlodipine 5 mg per tablet | Anhydrous dicalcium phosphate |
| AMLODIPINE 10 GDC | Amlodipine besylate | Equivalent to amlodipine 10 mg per tablet | Colloidal silicon dioxide |
| — | — | — | Magnesium stearate |
| — | — | — | Microcrystalline cellulose |
| — | — | — | Sodium starch glycollate |
Amlodipine is a scheduled medicine in South Africa. Detailed information, including its uses, warnings, precautions, dosage guidance and possible side effects, is intended only for registered healthcare professionals or for patients to whom the medicine has been legally prescribed.
This page does not provide medical advice, treatment recommendations, promotional claims, or instructions for use. Please consult a registered doctor, pharmacist, or other qualified healthcare professional for information specific to your condition and prescription.
For your safety, do not use Amlodipine unless it has been prescribed or supplied to you in accordance with South African medicine regulations .
Manufacturer/holder
Gulf Drug Company (Pty) Ltd
SAHPRA / product identifier : AMLODIPINE 5 GDC: 41/7.1/0812
AMLODIPINE 10 GDC: 41/7.1/0813
Sources
Written by: RxZest Editorial Team
Editorial review: Checked for readability, structure, and source alignment
Based on SAHPRA-approved information : Amlodipine
Last updated: [12/05/2026]
